Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 8Other hematologic neoplasm 7Myeloid 5Thoracic 4Head & Neck 3Gastrointestinal 3Breast 2Tumor-Agnostic 1Sarcoma 1Plasma cell 1Endocrine 1Dermatologic 1CNS 1

Conditions

Breast Neoplasms 2Hyperinsulinism 1

Interventions

Trastuzumab 732Paclitaxel 695Cyclophosphamide 647Docetaxel 560Capecitabine 486Letrozole 437Fulvestrant 400Carboplatin 398Doxorubicin 341Tamoxifen 308Anastrozole 279pembrolizumab 274exemestane 258Epirubicin 251pertuzumab 240Radiotherapy 239palbociclib 224Bevacizumab 222Gemcitabine 215Vinorelbine 197Lapatinib 181130-nm albumin-bound paclitaxel 172Magnetic Resonance Spectroscopy 164Albumin-Bound Paclitaxel 157eribulin 154Surveys and Questionnaires 152Exercise 151Drug Therapy 141Taxes 134Fluorouracil 133

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Pioglitazone × Breast × Clear all
NCT05013255 2025-04-08

Pioglitazone Therapy Targeting Fatigue in Breast Cancer

West Virginia University

Phase 2 Recruiting
30 enrolled
Breast

Breast Neoplasms

NCT05753657 2023-03-03

A Pilot Study of Monitoring Insulin Levels and Treating Hyperinsulinemia and Hyperglycemia With Pioglitazone in Patients Treated With Alpelisib for Metastatic Breast Cancer.

Rambam Health Care Campus

Phase EARLY_PHASE1 Recruiting
30 enrolled
Breast

Breast Neoplasms, Hyperinsulinism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡